Skip to main content
SpringerLink
Log in

Defibrotide versus Placebo in the Treatment of Intermittent Claudication

A Meta-Analysis

  • Short Communication
  • Published:
Drug Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Arosio E, Pancera P, Zannoni M, Arcaro G, Priante F, et al. Defibrotide and peripheral obliterative arterial disease: preliminary data. International Journal of Clinical Pharmacology Therapy and Toxicology 27: 526–529, 1989

    CAS  Google Scholar 

  • Avellone G, Di Garbo V, Cordova RM, Nazzari M, Bompiani G. Hemorheologic and antithrombotic effects of defibrotide in patients with claudicatio intermittens. Thrombotic and Haemorrhagic Disorders 7: 35–40, 1993

    Google Scholar 

  • Belfiglio A, Traietti P, Bologna E, Salvo G. Effects of oral and intravenous defibrotide on blood viscosity in patients with peripheral obliterative arterial disease. Clinical Therapeutics 11: 479–484, 1989

    PubMed  CAS  Google Scholar 

  • Boissel JP, Sacks HS, Leizorovicz A, Blanchard J, Panak E, et al. Meta-analysis of clinical trials: summary of an international conference. European Journal of Clinical Pharmacology 34: 535–538, 1988

    Article  PubMed  CAS  Google Scholar 

  • Cameron HA, Waller PC, Ramsay LE. Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965–1985. British Journal of Clinical Pharmacology 26: 569–576, 1988

    Article  PubMed  CAS  Google Scholar 

  • Cappelli R, Pecchi S, Pieragalli D. et al. Effect on rheological and some peripheral haemodynamic parameters of defibrotide in POAD patients. Clinical Hemorheology 7: 247–252, 1987

    Google Scholar 

  • Coccheri S, Biagi G. Defibrotide. Cardiovascular Drug Reviews 9: 172–196, 1991

    Article  CAS  Google Scholar 

  • Cochran WG. The combination of estimates from different experiments. Biometrics 10: 101–129, 1954

    Article  Google Scholar 

  • Colditz GA, Halvorsen KT, Goldhaber SZ. Randomised clinical trials of transdermal nitroglycerin systems for the treatment of angina: a meta analysis. American Heart Journal 116: 174–180, 1988

    Article  PubMed  CAS  Google Scholar 

  • Craveri A, Tomaghi G, Ranieri R, Stanzani M, Landi G, et al. Effects of defibrotide after oral and parenteral administration in patients with peripheral arterial disease (PAD). International Angiology 9: 274–277, 1990

    PubMed  CAS  Google Scholar 

  • De Luca N, Crispino MR, Marcheggiani R, et al. Terapia delle arteriopatie periferiche di tipo aterosclerotico con defibrotide somministrato per os: studio controllato in doppio cieco versus placebo. Medical Praxis 8: 1–8, 1987

    Google Scholar 

  • Di Perri T, Laghi Pasini F, Acciavatti A, et al. Haemodynamics rheology and mechanism of action of iloprost in man. Clinical Hemorheology 10: 171–183, 1990

    Google Scholar 

  • Lindgaerde F, Jelnes R, Adielsson G, et al. Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Circulation 80: 1549–1556, 1989

    Article  Google Scholar 

  • Marelli C, Belcaro G, Girardello R. Defibrotide in patients with intermittent claudication. Improvement in blood flow, fibrinolytic activity and microcirculation after six months of treatment. Current Therapeutic Research 47: 459–465, 1990

    Google Scholar 

  • Marrapodi E, Leanza D, Giordano S, Nazzari M, Corsi C. Effects of defibrotide on physical performance and hemorheology picture in patients with peripheral arteriopathy. Clinical Trials and Meta-Analysis, in press, 1994

    Google Scholar 

  • Palmer KJ, Goa KL. Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders. Drugs 45: 259–294, 1993

    Article  PubMed  CAS  Google Scholar 

  • Romeo S, Viola S, Bonaccorsi R, Iapichino G, Carullo F. II defibrotide nelle arteriopatie periferiche ostruttive. Studio policentrico. Medical Praxis 10: 141–149, 1989

    Google Scholar 

  • Sabba’ C, Zupo V, Dina F, Nazzari M, Albano O. A pilot evaluation of the effect of defibrotide in patients affected by peripheral arterial occlusive disease. International Journal of Clinical Pharmacology Therapy and Toxicology 26: 249–252, 1988

    Google Scholar 

  • Strano A, Fareed J, Sabba’ C, et al. A double blind, multicenter, placebo controlled, dose comparison study of orally administered defibrotide: preliminary results in patients with peripheral arterial disease. Seminars in Thrombosis and Hemostasis 17(Suppl. 2): 228–234, 1991

    PubMed  Google Scholar 

  • Ulutin ON. Clinical effectiveness of defibrotide in vasoocclusive disorders and its mode of actions. Seminars in Thrombosis and Hemostasis 14 (Suppl.): 58–63, 1988

    PubMed  Google Scholar 

  • Vogt MT, Wolfson SK, Kuller LH. Lower extremity arterial disease and the aging process: a review. Journal of Clinical Epidemiology 45: 529–542, 1992

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Department, Crinos SpA, Piazza XX Settembre, 2, 22079, Villa Guardia, CO, Italy

    Pierantonio Ferrari,  Giuseppina Clerici, Gualberto Gussoni & Marco Nazzari

Authors
  1. Pierantonio Ferrari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giuseppina Clerici
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gualberto Gussoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marco Nazzari
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ferrari, P., Clerici, G., Gussoni, G. et al. Defibrotide versus Placebo in the Treatment of Intermittent Claudication. Drug Invest 7, 157–160 (1994). https://doi.org/10.1007/BF03258468

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03258468

Search

Navigation